GB0326168D0 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number: GB0326168D0
Authority: GB; United Kingdom
Prior art keywords: chemical compounds; compounds; chemical
Prior art date: 2003-11-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB0326168.2A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Arrow Therapeutics Ltd

Original Assignee

Arrow Therapeutics Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-11-10

Filing date

2003-11-10

Publication date

2003-12-17

2003-11-10 Application filed by Arrow Therapeutics Ltd filed Critical Arrow Therapeutics Ltd

2003-11-10 Priority to GBGB0326168.2A priority Critical patent/GB0326168D0/en

2003-12-17 Publication of GB0326168D0 publication Critical patent/GB0326168D0/en

2004-11-10 Priority to PCT/GB2004/004744 priority patent/WO2005047288A1/en

Status Ceased legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Virology (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

GBGB0326168.2A 2003-11-10 2003-11-10 Chemical compounds Ceased GB0326168D0 (en)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
GBGB0326168.2A GB0326168D0 (en)	2003-11-10	2003-11-10	Chemical compounds
PCT/GB2004/004744 WO2005047288A1 (en)	2003-11-10	2004-11-10	Pyrazolopyrimidines as anti - hepatits c agents

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0326168.2A GB0326168D0 (en)	2003-11-10	2003-11-10	Chemical compounds

Publications (1)

Publication Number	Publication Date
GB0326168D0 true GB0326168D0 (en)	2003-12-17

Family

ID=29726249

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB0326168.2A Ceased GB0326168D0 (en)	2003-11-10	2003-11-10	Chemical compounds

Country Status (2)

Country	Link
GB (1)	GB0326168D0 (en)
WO (1)	WO2005047288A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1997644A (en) *	2004-03-02	2007-07-11	神经能质公司	Aryl substituted purine analogues
DK1907000T4 (en)	2005-06-08	2020-03-30	The President And Fellows Of Harvard College	Methods and compositions for treating persistent HIV infections by inhibiting the pathway of programmed cell death 1 (PD-1).
CN101384592A (en) *	2005-12-21	2009-03-11	艾博特公司	antiviral compound
EP2345652A1 (en) *	2005-12-21	2011-07-20	Abbott Laboratories	Antiviral compounds
TW200738707A (en) *	2005-12-21	2007-10-16	Abbott Lab	Anti-viral compounds
ATE475660T1 (en)	2005-12-21	2010-08-15	Abbott Lab	ANTIVIRAL COMPOUNDS
WO2007081517A2 (en) *	2005-12-21	2007-07-19	Abbott Laboratories	Anti-viral compounds
US7910595B2 (en) *	2005-12-21	2011-03-22	Abbott Laboratories	Anti-viral compounds
US7745636B2 (en)	2006-08-11	2010-06-29	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US8329159B2 (en)	2006-08-11	2012-12-11	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US8303944B2 (en)	2006-08-11	2012-11-06	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US7659270B2 (en)	2006-08-11	2010-02-09	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US7759495B2 (en)	2006-08-11	2010-07-20	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
EP2094276A4 (en)	2006-12-20	2011-01-05	Abbott Lab	Anti-viral compounds
KR20100130583A (en) *	2007-11-28	2010-12-13	다나-파버 캔서 인스티튜트 인크.	Small molecule myristate inhibitor of JCR-ALL and method of using the same
US8188098B2 (en)	2008-05-19	2012-05-29	Hoffmann-La Roche Inc.	GPR119 receptor agonists
EP2370593B1 (en)	2008-11-28	2016-03-30	Emory University	Methods for determining the efficacy of pd-1 antagonists
CN102180880B (en) *	2011-03-23	2014-04-09	常州大学	Method for synthesizing bromophenyl pyrazolo[3,4-d]pyrimidine derivative
CN102115475B (en) *	2011-03-23	2013-01-16	常州大学	Method for synthesizing pyrazolo[3,4-d]pyrimidine derivative by two steps
CN102115476A (en) *	2011-03-23	2011-07-06	常州大学	2H-pyrazolo [3, 4-d] pyrimidine derivative and synthetic method thereof
EP2852595B1 (en)	2012-05-21	2016-06-22	Bayer Pharma Aktiengesellschaft	Substituted benzothienopyrimidines
WO2013182612A1 (en)	2012-06-07	2013-12-12	Bayer Pharma Aktiengesellschaft	Glucose transport inhibitors
CN102746306B (en) *	2012-07-09	2014-11-19	四川国康药业有限公司	Allopurinol derivative and preparation method and application thereof
CN103570723B (en) *	2012-07-27	2016-07-13	广西梧州制药（集团）股份有限公司	Pyrazolopyrimidine derivatives, preparation method thereof and use in medicine preparation
TW201412740A (en)	2012-09-20	2014-04-01	Bayer Pharma AG	Substituted pyrrolopyrimidinylamino-benzothiazolones
HK1222173A1 (en)	2013-02-01	2017-06-23	Bayer Pharma Aktiengesellschaft	Substituted pyrazolopyrimidinylamino-indazoles
CN106361753A (en) *	2016-11-13	2017-02-01	曹艳	Allopurinol derivative and application thereof to preparing anti-tumor medicine
CN117865965B (en) *	2024-01-08	2024-06-28	贵州省天然产物研究中心	Pyrrolopyrimidine-4-amine and pyrazolopyrimidine-4-amine derivatives and preparation methods and applications thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW444018B (en) *	1992-12-17	2001-07-01	Pfizer	Pyrazolopyrimidines
JP3580377B2 (en) *	1993-06-29	2004-10-20	三菱化学株式会社	Phosphonate nucleotide ester derivatives
DE69426904T2 (en) *	1993-06-29	2001-10-11	Mitsubishi Chemical Corp., Tokio/Tokyo	Phosphonate nucleotide ester derivatives

2003
- 2003-11-10 GB GBGB0326168.2A patent/GB0326168D0/en not_active Ceased
2004
- 2004-11-10 WO PCT/GB2004/004744 patent/WO2005047288A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO2005047288A1 (en)	2005-05-26

Publication	Publication Date	Title
GB0317009D0 (en)	2003-08-27	Chemical compounds
GB0304194D0 (en)	2003-03-26	Chemical compounds
GB0308208D0 (en)	2003-05-14	Chemical compounds
GB0319124D0 (en)	2003-09-17	Chemical compounds
GB0311276D0 (en)	2003-06-18	Chemical compounds
GB0319126D0 (en)	2003-09-17	Chemical compounds
GB0315203D0 (en)	2003-08-06	Chemical compounds
GB0311274D0 (en)	2003-06-18	Chemical compounds
GB0321827D0 (en)	2003-10-15	Chemical compounds
EP1590339A4 (en)	2007-07-25	Chemical compounds
GB0319759D0 (en)	2003-09-24	Chemical compounds
GB0318422D0 (en)	2003-09-10	Chemical compounds
GB0318423D0 (en)	2003-09-10	Chemical compounds
EP1654251A4 (en)	2009-03-11	Chemical compounds
GB0308801D0 (en)	2003-05-21	Chemical compounds
GB0319690D0 (en)	2003-09-24	Chemical compounds
GB0310724D0 (en)	2003-06-11	Chemical compounds
GB0306358D0 (en)	2003-04-23	Chemical compounds
GB0306357D0 (en)	2003-04-23	Chemical compounds
GB0314373D0 (en)	2003-07-23	Chemical compounds
GB0304723D0 (en)	2003-04-02	Chemical compounds
GB0310464D0 (en)	2003-06-11	Chemical compounds
GB0314370D0 (en)	2003-07-23	Chemical compounds
GB0319149D0 (en)	2003-09-17	Chemical compounds
GB0315872D0 (en)	2003-08-13	Chemical compounds

Legal Events

Date	Code	Title	Description
2004-12-15	AT	Applications terminated before publication under section 16(1)